Friday, 4 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 2, 2026

Trending tickers: Palantir, Berkshire Hathaway, Lockheed Martin, Exxon Mobil and Bunzl

View original at uk.finance.yahoo.com
Trending tickers: Palantir, Berkshire Hathaway, Lockheed Martin, Exxon Mobil and Bunzl Palantir (PLTR) Shares of Palantir were the top-trending ticker on Yahoo Finance on Monday morning after UBS (UBS) upgraded the company…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Palantir stock is very attractive at 50 times UBS's 2027 free cash flow estimates given 70% revenue growth in 2026 and mid-50% operating margins

    80% confidence
  • Palantir is facing a very strong demand backdrop as it sits at the intersection of AI and data spend. This investment ramp in AI models and data is occurring right now, with Palantir a clear AI winner

    80% confidence
  • The push for additional military funding may now spread to the Middle East, with US contractors capturing much of that new business from the region which already accounts for a significant portion of their foreign military sales

    80% confidence
  • In the current scenario, oil prices over US$100/bbl are possible if transit flows are not re-established quickly. The key question is when do vessels re-establish export flows.

    80% confidence
  • The most immediate and tangible development affecting oil markets is the effective halt of traffic through the Strait of Hormuz, preventing 15 million barrels per day of crude oil from reaching markets. Unless de-escalation signals emerge swiftly, we expect a significant upward repricing of oil.

    80% confidence
  • The market will take this as broadly positive for European defense stocks, though any move is likely to be driven more by sentiment than by changes to earnings estimates

    80% confidence
  • For the most part, Bunzl remains a well-run if not currently well-regarded stock. The outlook provides little for the bulls to feed on. The market consensus of hold reflects investors' reticence to become involved until a sustained recovery is in evidence.

    80% confidence
  • Investors should consider taking advantage of this -35% move off the peak for the premier growth story in software

    80% confidence
  • Higher oil and gas prices are almost certain, with prices possibly exceeding $100 per barrel if tanker flows through the Strait of Hormuz are not quickly restored

    80% confidence
  • After a couple of bruising years for the share price, Bunzl investors were handed a steadier, if hardly sparkling, set of results. Management's interventions in North America including leadership changes and cost controls appear to be paying off.

    80% confidence
  • Greg Abel will continue the culture Buffett built of financial strength and capital discipline

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Trending tickers: Palantir, Berkshire Hathaway, Lockheed Martin, Exxon Mobil and Bunzl — Source | Via News | ViaNews EU